THrombolysis for Acute Wake-up and Unclear-onset Strokes With Alteplase at 0.6 mg/kg Trial (THAWS)
Latest Information Update: 03 Oct 2023
Price :
$35 *
At a glance
- Drugs Alteplase (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Acronyms THAWS
- 19 Mar 2021 Results of a prespecified sub-analysis assessing potential effect of prior antithrombotic medication for thrombolysis using alteplase at 0.6mg/kg in unknown onset stroke presented at the International Stroke Conference 2021
- 10 Dec 2020 Results of subanalysis of this study identifying patients with unknown onset stroke who could have favorable outcomes after low-dose thrombolysis published in the Stroke
- 06 Apr 2020 Primary endpoint (Modified Rankin Scale 0-1) 346has not been met.